Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-26

Clinical Trial Update: Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating adding clofarabine to standard busulfan/fludarabine conditioning for allogeneic hematopoietic cell transplantation has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUSULFAN (Busulfan)
  • Clofarabine (clofarabine)
  • Fludarabine (Fludarabine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Myeloid Malignancy, Bone Marrow Failure Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2020-02-26